ARKG Holdings of Personalis (PSNL) - Updated Daily
Liquid BiopsyGenomicsGenetic Testing
Key Statistics
Statistics
| ⚖️Weighting | 🧢Market Cap |
|---|---|
| 0.53% | $89.82m |
| 🏋🏿♂️Weight Rank In ARKG | 🌏Country |
| 37 | 🇺🇸United States |
| 🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
| 100 | |
| 🎫ARK Ownership Percent | |
| 12.24% | |
| Description | |
|---|---|
| personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer. | |
| Website | |
| personalis.com |
Other ETFs That Hold PSNL
Research Notes and Commentary for PSNL
No Research Notes Found for PSNL